会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 14. 发明授权
    • Graft-versus-host disease predicting marker and use thereof
    • 移植物抗宿主病预测标记及其用途
    • US08603754B2
    • 2013-12-10
    • US13204799
    • 2011-08-08
    • Akira ShibuyaHiroshi Kojima
    • Akira ShibuyaHiroshi Kojima
    • G01N33/53
    • G01N33/573A61K39/3955A61K2039/505C07K16/2803G01N2333/91245G01N2800/245
    • A test method that provides data useful in predicting the probability of onset of acute graft-versus-host disease (GVHD) is described along with a kit for performing the method, and a pharmaceutical preparation and a molecular targeted therapy for treating or preventing GVHD. The test method includes measuring the blood DNAM-1 concentration of a patient of hematopoietic stem cell transplantation from bone marrow or the like over a period after the transplantation to provide data concerning the transition of the concentration to an abnormally high level deviating from the normal range, whereby the probability of the development of acute graft-versus-host disease is predicted, the risk of the development is estimated, or therapeutic effects after the development are evaluated. Concerning the molecular targeted therapy and pharmaceutical preparation used therefor wherein blood DNAM-1 of a GVHD patient or a graft recipient that is a possible patient is used as a target molecule, GVHD is treated or prevented by administering an anti-DNAM-1 antibody that is a neutralizing antibody.
    • 描述了提供用于预测急性移植物抗宿主病(GVHD)发病概率的数据的测试方法以及用于进行该方法的试剂盒以及用于治疗或预防GVHD的药物制剂和分子靶向治疗。 测试方法包括在移植后的一段时间内测量来自骨髓等的造血干细胞移植患者的血液DNAM-1浓度,以提供关于浓度向偏离正常范围的异常高水平转变的数据 预测急性移植物抗宿主病发展的可能性,估计发展的风险,或发展后的治疗效果。 关于其中使用的分子靶向治疗和药物制剂,其中GVHD患者的血液DNAM-1或作为可能患者的移植物接受体用作靶分子,通过施用抗-DNAM-1抗体来治疗或预防GVHD, 是中和抗体。
    • 15. 发明授权
    • Method for producing β-mercapto carboxylic acids
    • - 巯基羧酸的生产方法
    • US08258340B2
    • 2012-09-04
    • US12921495
    • 2009-03-11
    • Hidemasa AokiAkio KuroiwaAkira Shibuya
    • Hidemasa AokiAkio KuroiwaAkira Shibuya
    • C07B53/00
    • C07C319/04C07C323/56C07C323/52
    • An object of the present invention is to provide a method for industrially producing β-mercapto carboxylic acids that are useful as synthetic raw materials for medicines and agrochemicals or as additives for polymer compounds from easily available α,β-unsaturated carboxylic acids in high yields and productivity.The present invention is characterized in that a solvent having an amide group and represented by the formula (1) is used when the α,β-unsaturated carboxylic acids are reacted with hydrogen sulfides to produce the β-mercapto carboxylic acids. Particularly, it is more preferable to carry out the reaction at a pH range of 6.0 to 8.5: (In the formula (1), R1 represents any one of a hydrogen atom, an alkoxy group having 1 to 5 carbon atoms, an alkyl group having 1 to 5 carbon atoms, an amino group, and an alkylamino group having 1 to 5 carbon atoms; R2 and R3 each represents independently any one of a hydrogen atom and an alkyl group having 1 to 5 carbon atoms; when both R2 and R3 are not a hydrogen atom, R2 and R3 may together form a ring structure through an alkylene group; and when both R1 and R2 are not a hydrogen atom, R1 and R2 may form a ring structure through an alkylene group).
    • 本发明的一个目的是提供一种工业上生产和/或巯基羧酸的方法,其可用作药物和农用化学品的合成原料或作为高分子化合物的添加剂,其易于获得的α,β-不饱和羧酸在高 产量和生产力。 本发明的特征在于,当α,bgr-不饱和羧酸与硫化氢反应以制备β-巯基羧酸时,使用具有酰胺基并由式(1)表示的溶剂。 特别优选在6.0〜8.5的pH范围进行反应(式(1)中,R 1表示氢原子,碳原子数1〜5的烷氧基,烷基 具有1至5个碳原子,氨基和具有1至5个碳原子的烷基氨基; R 2和R 3各自独立地表示氢原子和具有1至5个碳原子的烷基中的任一个;当R 2和R 3均为 不是氢原子,R2和R3可以一起通过亚烷基形成环结构;当R1和R2都不是氢原子时,R1和R2可以通过亚烷基形成环结构)。
    • 16. 发明申请
    • Graft-Versus-Host Disease Predicting Marker and Use Thereof
    • 移植物抗宿主病预测标记及其用途
    • US20110318762A1
    • 2011-12-29
    • US13204799
    • 2011-08-08
    • Akira ShibuyaHiroshi Kojima
    • Akira ShibuyaHiroshi Kojima
    • G01N33/577
    • G01N33/573A61K39/3955A61K2039/505C07K16/2803G01N2333/91245G01N2800/245
    • A test method that provides data useful in predicting the probability of onset of acute graft-versus-host disease (GVHD) is described along with a kit for performing the method, and a pharmaceutical preparation and a molecular targeted therapy for treating or preventing GVHD. The test method includes measuring the blood DNAM-1 concentration of a patient of hematopoietic stem cell transplantation from bone marrow or the like over a period after the transplantation to provide data concerning the transition of the concentration to an abnormally high level deviating from the normal range, whereby the probability of the development of acute graft-versus-host disease is predicted, the risk of the development is estimated, or therapeutic effects after the development are evaluated. Concerning the molecular targeted therapy and pharmaceutical preparation used therefor wherein blood DNAM-1 of a GVHD patient or a graft recipient that is a possible patient is used as a target molecule, GVHD is treated or prevented by administering an anti-DNAM-1 antibody that is a neutralizing antibody.
    • 描述了提供用于预测急性移植物抗宿主病(GVHD)发病概率的数据的测试方法以及用于进行该方法的试剂盒以及用于治疗或预防GVHD的药物制剂和分子靶向治疗。 测试方法包括在移植后的一段时间内测量来自骨髓等的造血干细胞移植患者的血液DNAM-1浓度,以提供关于浓度向偏离正常范围的异常高水平转变的数据 预测急性移植物抗宿主病发展的可能性,估计发展的风险,或发展后的治疗效果。 关于其中使用的分子靶向治疗和药物制剂,其中GVHD患者的血液DNAM-1或作为可能患者的移植物接受体用作靶分子,通过施用抗-DNAM-1抗体来治疗或预防GVHD, 是中和抗体。
    • 17. 发明授权
    • Graft-versus-host disease predicting marker and use thereof
    • 移植物抗宿主病预测标记及其用途
    • US08153130B2
    • 2012-04-10
    • US12296345
    • 2007-04-05
    • Akira ShibuyaHiroshi Kojima
    • Akira ShibuyaHiroshi Kojima
    • A61K39/395
    • G01N33/573A61K39/3955A61K2039/505C07K16/2803G01N2333/91245G01N2800/245
    • A test method that provides data useful in predicting the probability of onset of acute graft-versus-host disease (GVHD) is described along with a kit for performing the method, and a pharmaceutical preparation and a molecular targeted therapy for treating or preventing GVHD. The test method includes measuring the blood DNAM-1 concentration of a patient of hematopoietic stem cell transplantation from bone marrow or the like over a period after the transplantation to provide data concerning the transition of the concentration to an abnormally high level deviating from the normal range, whereby the probability of the development of acute graft-versus-host disease is predicted, the risk of the development is estimated, or therapeutic effects after the development are evaluated. Concerning the molecular targeted therapy and pharmaceutical preparation used therefor wherein blood DNAM-1 of a GVHD patient or a graft recipient that is a possible patient is used as a target molecule, GVHD is treated or prevented by administering an anti-DNAM-1 antibody that is a neutralizing antibody.
    • 描述了提供用于预测急性移植物抗宿主病(GVHD)发病概率的数据的测试方法以及用于进行该方法的试剂盒以及用于治疗或预防GVHD的药物制剂和分子靶向治疗。 测试方法包括在移植后的一段时间内测量来自骨髓等的造血干细胞移植患者的血液DNAM-1浓度,以提供关于浓度向偏离正常范围的异常高水平转变的数据 预测急性移植物抗宿主病发展的可能性,估计发展的风险,或发展后的治疗效果。 关于其中使用的分子靶向治疗和药物制剂,其中GVHD患者的血液DNAM-1或作为可能患者的移植物接受体用作靶分子,通过施用抗-DNAM-1抗体来治疗或预防GVHD, 是中和抗体。
    • 20. 发明授权
    • Electric dust collecting apparatus
    • 电动除尘装置
    • US3994704A
    • 1976-11-30
    • US565821
    • 1975-04-07
    • Akira ShibuyaYoshifumi Nitta
    • Akira ShibuyaYoshifumi Nitta
    • B03C3/00B03C3/04B03C3/51B03C3/45
    • B03C3/51B03C3/04
    • An improved dust collecting apparatus is described, in a first section of which are disposed a plurality of linear discharge electrodes and a plurality of planar dust collecting electrodes in an opposed relationship to each other within a casing that has an inlet port for introducing a dust-containing gas formed at one end and that has an outlet port for discharging a dust-free gas formed at the other end, so that the dust in the dust-containing gas may be charged and also collected in said first section. Downstream of said first section of the apparatus are aligned a plurality of rod-shaped driver electrodes spaced apart from each other along a plane transverse of a gas flow, and on the side surfaces of said driver electrodes are provided lengthwise channels having their openings directed to the outlet port side. Downstream of the gas spaces formed between adjacent ones of said driver electrodes are disposed a plurality of rod-shaped collector electrodes, and on the side surfaces of said collector electrodes are provided lengthwise channels having their openings directed to the inlet port side. A negative terminal of a D.C. power source is connected to said driver electrodes, while a positive terminal of a D.C. power source is connected to said collector electrodes, whereby the dust that has been charged in the space between said discharge electrodes and said dust collecting electrodes but has not adhered to the dust collecting electrodes and that has been respattered can be collected within the lengthwise channels of said collector electrodes.
    • 在第一部分中描述了一种改进的集尘装置,其中第一部分在壳体内彼此相对关系地设置有多个线性放电电极和多个平面集尘电极,该壳体具有用于引入除尘装置的入口, 形成在一端的容纳气体,具有用于排出在另一端形成的无尘气体的出口,使得含尘气体中的灰尘可能被填充并收集在所述第一部分中。 所述设备的所述第一部分的下游沿着沿着气流横向的平面彼此间隔开的多个杆状驱动器电极对准,并且在所述驱动电极的侧表面上设置有纵向通道,其开口指向 出口侧。 在相邻的所述驱动电极之间形成的气体空间的下游设置有多个棒状收集电极,并且在所述集电极的侧表面上设有纵向通道,其开口指向入口侧。 直流电源的负端子连接到所述驱动电极,而直流电源的正极端子连接到所述集电极,由此已经充电在所述放电电极和所述集尘电极之间的空间的灰尘 但是没有附着在集尘电极上,并且已经被重新分配的电极可以被收集在所述集电极的纵向通道内。